Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 383,315 | 365,854 | 366,190 | 357,082 | 368,602 |
| Cost of Goods | 146,464 | 143,245 | 137,565 | 144,222 | 148,171 |
| Gross Profit | 236,851 | 222,609 | 228,625 | 212,860 | 220,431 |
| Operating Expenses | 203,207 | 199,177 | 201,556 | 187,503 | 213,384 |
| Operating Income | 34,108 | 23,677 | 27,634 | 25,579 | 7,218 |
| Interest Expense | 13,933 | 14,478 | 17,504 | 18,768 | 16,946 |
| Other Income | 4,341 | 1,825 | 2,601 | 2,321 | 5,131 |
| Pre-tax Income | 24,516 | 11,024 | 12,731 | 9,132 | -4,597 |
| Income Tax | -622 | -2,271 | 1,355 | -1,860 | -48,952 |
| Net Income Continuous | 25,138 | 13,295 | 11,376 | 10,992 | 44,355 |
| Net Income | $25,138 | $13,295 | $11,376 | $10,992 | $44,355 |
| EPS Basic Total Ops | 0.29 | 0.16 | 0.14 | 0.14 | 0.57 |
| EPS Basic Continuous Ops | 0.30 | 0.16 | 0.14 | 0.14 | 0.57 |
| EPS Diluted Total Ops | 0.29 | 0.15 | 0.14 | 0.14 | 0.56 |
| EPS Diluted Continuous Ops | 0.30 | 0.15 | 0.14 | 0.14 | 0.56 |
| EBITDA(a) | $63,102 | $54,024 | $56,678 | $54,194 | $35,426 |